Quantifying antivascular effects of monoclonal antibodies to vascular endothelial growth factor:insights from imaging .Phase Ⅰ / Ⅱ trial evaluat-ing the anti-vascular endothelial growth factor monoclonal antibody bevacizumab in combination with the HER-1 ......